NORTHAMPTON, MA / ACCESS Newswire / May 15, 2025 / "Living with primary biliary cholangitis (PBC) can be an isolating experience," explains Dilek, a mother of two from Germany who suffers from the ...

(RTTNews) - Below are the earnings highlights for Planet Labs PBC (PL): Earnings: -$12.6 million in Q1 vs. -$29.3 million in the same period last year. EPS: -$0.04 in Q1 vs. -$0.10 in the same ...

The NDA is supported by data from the phase 3 GLISTEN study (ClinicalTrials.gov Identifier: NCT04950127), which included 238 adult PBC patients with cholestatic pruritus. Study participants were ...

Alcatel has made a comeback in India with the launch of the V3 series, which includes the V3 Classic, V3 Pro, and V3 Ultra. All the devices fall in the Rs 10,000- 20,000 price segment and are ...

Former 168-pound titleholder Caleb Plant (23-2, 14 KOs) will headline Saturday's PBC card (8 p.m. ET, Prime Video) in a 12-round bout against the hard-charging Armando Resendiz (15-2, 11 KOs).

The VANTAGE study is evaluating volixibat in patients with cholestatic pruritus caused by primary biliary cholangitis (PBC). "The extended VANTAGE analysis provides encouraging insights into the ...

We believe that linerixibat has the potential to make a difference in the lives of patients living with relentless itch associated with PBC and its related sleep interference. These are debilitating ...

Alcatel has just launched its latest smartphones in India, with the Alcatel V3 Classic 5G, V3 Pro 5G, and V3 Ultra 5G now available for purchase. Within a week of their debut, these models are ...

28-week data from the Phase 2b VANTAGE PBC study highlights statistically significant improvements in pruritus and numeric improvements in fatigue, the two most burdensome symptoms of PBC ...

Alcatel has unveiled its V3 series of smartphones, marking its re-entry into the Indian market. The lineup includes three models: the Alcatel V3 Classic, V3 Pro, and V3 Ultra. One of the major ...

GSK plc announced positive results from the GLISTEN phase III trial evaluating linerixibat, an investigational targeted inhibitor of the ileal bile acid transporter (IBAT), in adults with cholestatic ...

OpenAI's CFO, Sarah Friar, suggested that recent restructuring efforts, including becoming a public benefit corporation, ...